0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÎÀÎ¾Ï È¯ÀÚÀÇ ¸»ÃʽŰ溴Áõ°ú »îÀÇ Áú

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy

¿©¼º°Ç°­°£È£ÇÐȸÁö 2013³â 19±Ç 4È£ p.201 ~ 210
KMID : 0606420130190040201
Á¤ÁÖÇö ( Jeong Ju-Hyeon ) - ¼­¿ï¾Æ»êº´¿ø

³ëÁÖÈñ ( Nho Ju-Hee ) - ¿ï»ê´ëÇб³ °£È£Çаú
ÀÌ¿µÀº ( Lee Young-Eun ) - ¼­¿ï¾Æ»êº´¿ø
À¯¼±¿µ ( Yoo Sun-Young ) - ¼­¿ï¾Æ»êº´¿ø
ÀÌÇöÁÖ ( Lee Hyun-Ju ) - ¼­¿ï¾Æ»êº´¿ø
½ÉÀ¯¹Ì ( Sim Yu-Mi ) - ¼­¿ï¾Æ»êº´¿ø
ÀÌ¿µ¼± ( Lee Young-Sun ) - ¼­¿ï¾Æ»êº´¿ø

Abstract

Purpose: The purpose of this study was to identify chemotherapy induced peripheral neuropathy, quality of life of patients with gynecologic cancer.

Methods: This was a cross-sectional survey design. We collected 130 patients with gynecologic cancer. They complete a self reported questionnaire including items related neuropathy and quality of life (FACT-GOG/Ntx subscale, FACT-G scale).

Results: The neuropathy score was 14.3¡¾7.9. The quality of life score was 64.8¡¾16.4. The neuropathy induced significant difference according to diabetic status, difficulties in performing household chores and willing to discontinuity of chemotherapy. And duration of cancer diagnosis, neuropathy, number of total chemo agent associated with quality of life. There was a negative correlation between number of total chemo agent and quality of life. Neuropathy independently affected quality of life.

Conclusion: Chemotherapy induced peripheral neuropathy of patients with gynecologic cancer adversely affected women¡¯s quality of life and activities of daily living. To improve patient¡¯s quality of life, it is important that accurate assess and appropriately manage neuropathy in patients with gynecologic cancer.
KeyWords
ºÎÀξÏ, ¸»ÃʽŰ溴Áõ, »îÀÇ Áú
Gynecologic neoplasm, Chemotherapy induced peripheral neuropathy, Quality of life
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed